[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100519524":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":7,"centralContacts":8,"locations":14,"responsibleParty":34,"collaborators":7,"id":38,"slug":39,"hasResults":40,"nctId":41,"briefTitle":42,"officialTitle":43,"acronym":7,"eligibilityCriteria":44,"healthyVolunteers":40,"sex":45,"minAge":46,"maxAge":7,"enrollmentInfo":47,"targetDuration":7,"studyType":50,"phases":7,"briefSummary":51,"conditions":52,"keywords":54,"overallStatus":17,"whyStopped":7,"lastUpdateSubmitDate":58,"lastUpdatePostDateStruct":59,"startDateStruct":62,"completionDateStruct":64,"leadSponsor":66,"locationsCount":67},{"fullName":5,"class":6},"Rigshospitalet, Denmark","OTHER",null,[9],{"name":10,"role":11,"phone":12,"phoneExt":7,"email":13},"Tina Dysgaard, Dr.med.","CONTACT","±45 35458077","Tina.dysgaard@regionh.dk",[15],{"facility":16,"status":17,"city":18,"state":7,"zip":19,"country":20,"countryCode":21,"cosmosGeoPoint":22,"geoPoint":27,"contacts":28},"Copenhagen Neuromuscular Center, Department of Neurology, Rigshospitalet","RECRUITING","Copenhagen","2100","Denmark","DK",{"type":23,"coordinates":24},"Point",[25,26],12.56553,55.67594,{"lat":26,"lon":25},[29,31],{"name":30,"role":11,"phone":12,"phoneExt":7,"email":13},"Tina Dysgaard, Dr.mee",{"name":32,"role":11,"phone":7,"phoneExt":7,"email":33},"Louise Kodal, MD","Louise.boensdorff.sloth.01@regionh.dk",{"type":35,"investigatorFullName":36,"investigatorTitle":37,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"PRINCIPAL_INVESTIGATOR","Louise Sloth Kodal","MD","100519524","prognostic-value-of-biomarkers-in-polyneuropathy-100519524",false,"NCT06044662","Prognostic Value of Biomarkers in Polyneuropathy.","The Prognostic Value of Blood Biomarkers for Patients With Polyneuropathy.","Inclusion Criteria:\n\n* Minimum 18 years old.\n* Diagnosed with polyneuropathy, confirmed by nerve conduction study.\n* Can read and understand Danish.\n\nExclusion Criteria:\n\n* Inability to perform physical tests due to comorbidity not associated to the patient's polyneuropathy.","ALL","18 Years",{"count":48,"type":49},200,"ESTIMATED","OBSERVATIONAL","Biomarkers for prognosis of patients with polyneuropathy.",[53],"Polyneuropathies",[55,56,57],"polyneuropathy","biomarkers","cohort study","2024-04-09",{"date":60,"type":61},"2024-04-11","ACTUAL",{"date":63,"type":61},"2023-10-27",{"date":65,"type":49},"2026-10",{"name":5,"class":6},1]